Amicus Therapeutics, Inc. logo

Amicus Therapeutics, Inc. (FOLD)

Delisted
27 Apr 2026
NASDAQ (NMS) NASDAQ (NMS)
$
14. 49
0
0%
$
4.55B Market Cap
- P/E Ratio
- Div Yield
5.29M Volume
-0.45 Eps
$ 14.49
Previous Close
Day Range
14.49 14.49
Year Range
5.51 14.5
Want to track FOLD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Amicus Therapeutics, Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
BM
Berkeley Meredith Hughes Financial Services LLC
52 $360.24 $752 $391.76 108.75%
GLF
Groupe La Francaise Groupe La Francaise
939,655 $13.54M $13.59M $51,524.84 0.38%
GFM
GF Fund Management Co. Ltd. GF Fund Management Co. Ltd.
6,929 $67,900.67 $100,193 $32,292.33 47.56%
JCB
John Ciaran Burns Universal-Beteiligungs- und Servicegesellschaft mbH
176,804 $1.21M $2.56M $1.35M 111.95%
Brucke Financial Inc.
Brucke Financial Inc. Brucke Financial Inc.
10,567 $152,799 $152,799 - -
KGL
Kilter Group LLC Kilter Group LLC
170 $2,430.12 $2,459 $28.88 1.19%
Charles Hillier
Charles Hillier Cibra Capital Ltd.
1.69M $24.36M $24.4M $46,376 0.19%
Nicole Reese
Nicole Reese WPG Advisers LLC
17 $160 $160 - -